MolNFT v1 · #23269 · protein
Crystal structure of the sulfite mtmb complex
1TV4 · Monomethylamine methyltransferase MTMB1: “Crystal structure of the sulfite mtmb complex”. X-ray diffraction, 2 ligands (BG3, SO4), 2 pockets (best druggability 0.52). MolNFT v1 #23269 on GenesisL1: 3D structure, binding sites and…
- PDB
- 1TV4
- Type
- protein
- Length
- 457 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Monomethylamine methyltransferase MTMB1
- EC
- 2.1.1.-
- UniProt
- O30642
- Ligands
- BG3, SO4
- Pockets
- 2 · best druggability 0.52
Structure
x-ray diffraction · 1 distinct chain · 45% helix, 14% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Monomethylamine methyltransferase MTMB1 (EC 2.1.1.-) | protein | 457 | 45% helix, 14% strand | O30642 |
Ligands and binding sites
- BG3 · 3-methyl-5-sulfo-pyrrolidine-2-carboxylic acid · ligand · chains A
- SO4 · Sulfate ion · ion · 10 copies · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 221 | 0.52 | 0.76 | 29 | BG3 |
| 2 | 56 | 0.28 | 0.75 | 15 | empty |
Modifications
Observed in the structure: 1 covalent (covalent ligand).
Compared structures
- 1TV4 · Crystal structure of the sulfite MtmB complex · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt O30642
- Elsewhere: RCSB PDB 1TV4 · PDBe 1TV4 · UniProt O30642
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.